NEI
MRNA icon

Northwest & Ethical Investments’s Moderna MRNA Stock Holding History

Northwest & Ethical Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,716
Closed -$341K – 551
2026
Q1 		$341K Sell
6,716
-8,036
-54% -$375K 0.01% 441
2025
Q4 		$435K Sell
14,752
-9,080
-38% -$247K 0.01% 407
2025
Q3 		$616K Hold
23,832
– – 0.01% 385
2025
Q2 		$658K Buy
23,832
+1,370
+6% +$36.1K 0.02% 375
2025
Q1 		$637K Sell
22,462
-21,004
-48% -$745K 0.02% 370
2024
Q4 		$1.81M Buy
43,466
+29,398
+209% +$1.41M 0.05% 261
2024
Q3 		$940K Sell
14,068
-1,387
-9% -$127K 0.02% 301
2024
Q2 		$1.84M Hold
15,455
– – 0.05% 254
2024
Q1 		$1.65M Hold
15,455
– – 0.05% 260
2023
Q4 		$1.54M Hold
15,455
– – 0.05% 250
2023
Q3 		$1.6M Hold
15,455
– – 0.05% 247
2023
Q2 		$1.88M Buy
15,455
+877
+6% +$117K 0.06% 250
2023
Q1 		$2.24M Buy
14,578
+1,983
+16% +$327K 0.07% 245
2022
Q4 		$2.26M Buy
12,595
+1,551
+14% +$254K 0.08% 234
2022
Q3 		$1.31M Hold
11,044
– – 0.05% 271
2022
Q2 		$1.58M Buy
11,044
+642
+6% +$91.8K 0.06% 261
2022
Q1 		$1.79M Buy
+10,402
New +$1.75M 0.06% 259

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Northwest & Ethical Investments's MRNA Position: Q2 2026 in Review

Northwest & Ethical Investments sold out of Moderna (MRNA) in Q2 2026, closing a stake of 6,716 shares — an estimated $341K sold.

Northwest & Ethical Investments first reported a position in MRNA in Q1 2022 and held it in 17 quarters. The position peaked at $2.26M in Q4 2022. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Northwest & Ethical Investments reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Northwest & Ethical Investments sold 6,716 Moderna shares in Q2 2026, an estimated $341K.
  • Northwest & Ethical Investments first reported a position in Moderna in Q1 2022 and held it in 17 quarters.
  • Northwest & Ethical Investments's Moderna position peaked at $2.26M in Q4 2022.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.